Results 301 to 310 of about 1,519,715 (337)
Dosimetric investigation of multi-parametric 4D-MRI for radiotherapy in liver cancer. [PDF]
Radiat OncolLi S +7 more
europepmc +1 more source
Immunotherapy targeting liver cancer tumor-initiating cells: challenges, mechanisms, and emerging therapeutic horizons. [PDF]
Front ImmunolChai Y +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Scottish Medical Journal, 1990
There has been a gradual change in the pattern of presentation of pyogenic liver abscess with an increasing incidence in the elderly.1 At the same time an improvement in mortality with early diagnosis and treatment has been recognised.2 We describe two patients in whom the diagnosis of liver abscess was not suspected until autopsy in one and ...
S.P. Wilkinson +2 more
openaire +3 more sources
There has been a gradual change in the pattern of presentation of pyogenic liver abscess with an increasing incidence in the elderly.1 At the same time an improvement in mortality with early diagnosis and treatment has been recognised.2 We describe two patients in whom the diagnosis of liver abscess was not suspected until autopsy in one and ...
S.P. Wilkinson +2 more
openaire +3 more sources
Obesity and Liver Cancer [PDF]
Clinics in Liver Disease, 2014 Obesity is an established risk factor for many types of cancers, particularly for hepatocellular carcinoma (HCC), owing to its carcinogenic potential and the association with nonalcoholic fatty liver disease (NAFLD). HCC may develop in cirrhotic and noncirrhotic livers with NAFLD, particularly in the presence of multiple metabolic risk factors such as ...
VANNI, Ester, BUGIANESI, Elisabetta
openaire +3 more sources
Clinics in Liver Disease, 2001
The prognosis of patients with HCC remains dismal. Even in the subgroups of patients who have the most favorable characteristics and are eligible for surgical resection, the 5-year survival rate is less than 25%. For patients with more advanced disease, the median survival time is less than 1 year.
A, Aguayo, Y Z, Patt
openaire +2 more sources
The prognosis of patients with HCC remains dismal. Even in the subgroups of patients who have the most favorable characteristics and are eligible for surgical resection, the 5-year survival rate is less than 25%. For patients with more advanced disease, the median survival time is less than 1 year.
A, Aguayo, Y Z, Patt
openaire +2 more sources
Current Oncology Reports, 1997
Hepatocellular carcinoma (HCC) is among the most prevalent and deadly cancers worldwide. Elevated incidence of HCC is strongly associated with hepatitis B virus infection and dietary exposure to hepatotoxic contaminants. Vaccination programs against viral hepatitis hold hope for the eventual reduction of HCC incidence, and screening of cirrhotic ...
Kathryn Z. Guyton, Thomas W. Kensler
openaire +5 more sources
Hepatocellular carcinoma (HCC) is among the most prevalent and deadly cancers worldwide. Elevated incidence of HCC is strongly associated with hepatitis B virus infection and dietary exposure to hepatotoxic contaminants. Vaccination programs against viral hepatitis hold hope for the eventual reduction of HCC incidence, and screening of cirrhotic ...
Kathryn Z. Guyton, Thomas W. Kensler
openaire +5 more sources
Current Opinion in Gastroenterology, 1989
The prognosis for the patient with liver cancer remains poor, despite advances in our understanding of the pathogenesis, in detection and in treatment. Nonetheless, there has been a reappraisal of the management of both primary and secondary liver cancer in recent years.
O. J. Garden, H. Bismuth
openaire +4 more sources
The prognosis for the patient with liver cancer remains poor, despite advances in our understanding of the pathogenesis, in detection and in treatment. Nonetheless, there has been a reappraisal of the management of both primary and secondary liver cancer in recent years.
O. J. Garden, H. Bismuth
openaire +4 more sources